Interleukin-6 (IL-6) is a cytokine that has been implicated as a growth factor in human ovarian carcinoma, yet the in vivo source of IL-6 in patients remains undefined. We measured IL-6 by ELISA in cell-free ascites (CFA) of 19 patients with ovarian carcinoma. IL-6 was detectable in all samples (mean level 3.3 ng/ml). To identify the cellular source of IL-6, we measured this cytokine by ELISA in 24-48 h supernatants of cultured lymphocyte-, macrophage-, and tumor cell-enriched populations purified from three solid ovarian carcinomas by centrifugal elutriation. All cell populations spontaneously released IL-6; however, tumor cells and tumor-associated macrophage released levels of IL-6 that greatly exceeded those released by tumor-associated lymphocytes.
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DISCUSSION
We detected IL-6 ranging from 0.4 to 20.4 ng/ml by ELISA in the CFA of 19 patients with advanced ovarian adenocarcinoma at the time of diagnosis. This is consistent with the work of other investigators , (26, 27) who in addition demonstrated significantly lower levels of IL-6 in benign peritoneal fluids. We also noted considerable variability in ascitic IL-6 levels found among patients with advanced disease. Berek 
